Interest of Occlusion of Permeable Foramen Ovale After a Cryptogenic Cerebrovascular Accident (CVA)
Information source: Nantes University Hospital
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Permeable Foramen Ovale; Cerebrovascular Accident
Intervention: Data collection (Other)
Phase: N/A
Status: Recruiting
Sponsored by: Nantes University Hospital Overall contact:
Patrice Guérin, MD, Phone: 0240087868, Email: patrice.guerin@chu-nantes.fr
Summary
Facing the lack of recommandations of Neurology and cardiology societies, the investigators
decided in 2002 some Good Medical Practices to define a specific and precise population for
whom the closure of permeable oval formaen after a first CVA seem to be necessary. Current
survey of these patients after implantation of a prothesis in interauricular septum is
defined by a consultation at 1, 3 and 6 months after surgery for a clinical exam and an
echocardiography. One year after implantation, the investigators systematically realized a
control by MRI associated to a contrast echography.
In the aim of evaluating the investigators' medical practice, the investigators decided to
do an observational study which will permit us to judge of the interest or lack of interest
of our "Good medical practice" before the publication of prospective and randomised clinical
studies.
Clinical Details
Official title: Interest of Occlusion of Permeable Foramen Ovale After a Cryptogenic Cerebrovacular Accident.
Study design: Cohort, Retrospective
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- less than 55 years old
- occlusion of FOP after cryptogenic CVA
Exclusion Criteria:
- characterized thromboembolic event
- patients who have a surgery after transitory ischemic accident
Locations and Contacts
Patrice Guérin, MD, Phone: 0240087868, Email: patrice.guerin@chu-nantes.fr
Nantes University Hospital, Nantes 44093, France; Recruiting
Patrice Guerin, MD, Phone: 0240087868, Email: patrice.guerin@chu-nantes.fr
Patrice Guérin, MD, Principal Investigator
Additional Information
Starting date: November 2008
Last updated: March 30, 2009
|
